FDA approves Rukobia for the treatment of adults with multidrug-resistant HIV-1 infection July 3, 2020 No Comments
GlaxoSmithKline and collaborators identify NF-kappaB activators/HIV latency-reversing agents June 18, 2020 No Comments
FDA approves dispersible tablet formulation of dolutegravir for infants and children with HIV June 15, 2020 No Comments
HPTN 083 interim analysis shows LA cabotegravir highly effective at preventing HIV May 18, 2020 No Comments
RSS